Your browser doesn't support javascript.
loading
Refinement of variant selection for the LDL cholesterol genetic risk score in the diagnosis of the polygenic form of clinical familial hypercholesterolemia and replication in samples from 6 countries.
Futema, Marta; Shah, Sonia; Cooper, Jackie A; Li, KaWah; Whittall, Ros A; Sharifi, Mahtab; Goldberg, Olivia; Drogari, Euridiki; Mollaki, Vasiliki; Wiegman, Albert; Defesche, Joep; D'Agostino, Maria N; D'Angelo, Antonietta; Rubba, Paolo; Fortunato, Giuliana; Walus-Miarka, Malgorzata; Hegele, Robert A; Aderayo Bamimore, Mary; Durst, Ronen; Leitersdorf, Eran; Mulder, Monique T; Roeters van Lennep, Jeanine E; Sijbrands, Eric J G; Whittaker, John C; Talmud, Philippa J; Humphries, Steve E.
Afiliação
  • Futema M; Centre for Cardiovascular Genetics, British Heart Foundation Laboratories, Institute of Cardiovascular Sciences, and.
  • Shah S; UCL Genetics Institute, Department of Genetics, Environment and Evolution, London, University College London, UK; Current affiliation: Centre for Neurogenetics and Statistical Genomics, Queensland Brain Institute, University of Queensland, St. Lucia, Brisbane, Australia;
  • Cooper JA; Centre for Cardiovascular Genetics, British Heart Foundation Laboratories, Institute of Cardiovascular Sciences, and.
  • Li K; Centre for Cardiovascular Genetics, British Heart Foundation Laboratories, Institute of Cardiovascular Sciences, and.
  • Whittall RA; Centre for Cardiovascular Genetics, British Heart Foundation Laboratories, Institute of Cardiovascular Sciences, and.
  • Sharifi M; Centre for Cardiovascular Genetics, British Heart Foundation Laboratories, Institute of Cardiovascular Sciences, and.
  • Goldberg O; Centre for Cardiovascular Genetics, British Heart Foundation Laboratories, Institute of Cardiovascular Sciences, and.
  • Drogari E; 1st Department of Pediatrics, Unit of Metabolic Diseases, Choremio Research Laboratory, University of Athens Medical School, "Aghia Sophia" Children's Hospital, Athens, Greece;
  • Mollaki V; 1st Department of Pediatrics, Unit of Metabolic Diseases, Choremio Research Laboratory, University of Athens Medical School, "Aghia Sophia" Children's Hospital, Athens, Greece;
  • Wiegman A; Department of Pediatrics and.
  • Defesche J; Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands;
  • D'Agostino MN; CEINGE S.C.a r.l. Advanced Biotechnology, Naples, Italy; Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy;
  • D'Angelo A; CEINGE S.C.a r.l. Advanced Biotechnology, Naples, Italy; Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy;
  • Rubba P; Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy;
  • Fortunato G; CEINGE S.C.a r.l. Advanced Biotechnology, Naples, Italy; Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy;
  • Walus-Miarka M; Department of Metabolic Diseases and Department of Medical Didactics, Jagiellonian University Medical College, Krakow, Poland;
  • Hegele RA; Robarts Research Institute, London, Ontario, Canada;
  • Aderayo Bamimore M; Robarts Research Institute, London, Ontario, Canada;
  • Durst R; Center for Research, Prevention and Treatment of Atherosclerosis, Department of Medicine, Cardiology Division, Hadassah Hebrew University Medical Centre, Jerusalem, Israel;
  • Leitersdorf E; Center for Research, Prevention and Treatment of Atherosclerosis, Department of Medicine, Cardiology Division, Hadassah Hebrew University Medical Centre, Jerusalem, Israel;
  • Mulder MT; Departments of Cardiology and Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands;
  • Roeters van Lennep JE; Departments of Cardiology and Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands;
  • Sijbrands EJ; Departments of Cardiology and Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands;
  • Whittaker JC; Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK; GlaxoSmithKline Quantitative Sciences, Medicines Research Centre, Stevenage, Hertfordshire, UK.
  • Talmud PJ; Centre for Cardiovascular Genetics, British Heart Foundation Laboratories, Institute of Cardiovascular Sciences, and.
  • Humphries SE; Centre for Cardiovascular Genetics, British Heart Foundation Laboratories, Institute of Cardiovascular Sciences, and steve.humphries@ucl.ac.uk.
Clin Chem ; 61(1): 231-8, 2015 Jan.
Article em En | MEDLINE | ID: mdl-25414277
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Herança Multifatorial / Polimorfismo de Nucleotídeo Único / Hiperlipoproteinemia Tipo II / LDL-Colesterol Tipo de estudo: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Female / Humans / Male / Middle aged País/Região como assunto: America do norte / Asia / Europa Idioma: En Revista: Clin Chem Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Herança Multifatorial / Polimorfismo de Nucleotídeo Único / Hiperlipoproteinemia Tipo II / LDL-Colesterol Tipo de estudo: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Female / Humans / Male / Middle aged País/Região como assunto: America do norte / Asia / Europa Idioma: En Revista: Clin Chem Ano de publicação: 2015 Tipo de documento: Article